Call for Application 2022 Opening soon!
Next Roadshow November 17th
Program Duration 9 months
Ablatus is the creator of Luna, a minimally invasive, uterus-preserving, and inclusive treatment for fibroids. These tumours, which grows in the womb affect up to 80% of women by the age of 50 - with up to half of them affected with debilitating symptoms like period for up to 21 days, impacting quality of life, fertility, and productivity.
Luna is powered by our patented enhanced ablation platform that can be used to destroy cancerous and non-cancerous soft tissues.
Treatment is delivered via a steerable probe through the cervix to tackle hard-to-reach fibroids for up to 80% of women currently not eligible for state-of-the-art technologies without removing the uterus but wishing to avoid invasive surgery.
Stealth mode
Babyndex, created by a gynecologist and his economist son, features an FDA-approved microscope paired with a mobile app to analyze saliva crystals for fertility tracking. The app identifies the most fertile days, helping women to effectively track their fertility. Available for iOS and Android, Babyndex is proven to aid users trying to conceive, offering a user-friendly design and reliable results.
Calico Biosystems is addressing the critical unmet need of the poor efficacy of cancer therapeutics for female patients with cancers. Cancer is a leading cause of death which kills one in six women. A main cause is the artificial models currently used for testing anti-cancer drug efficacy; they fail to recapitulate patient tumor complexity. Consequently, most anti-cancer drugs fail to reach approval due to a lack of efficacy and are extremely costly to develop. Further, approved anti-cancer drugs benefit only 10% of cancer patients. Calico Biosystems is the first platform testing drugs directly on female patient tumors thus predicting reliably at the pre-clinical stage the efficacy of drugs in patients.
Calico Biosystems drug testing platform is a game changer in precision oncology with aims at delivering female cancer patients with more potent and affordable drugs.
Being part of Tech4Eva brought us 2 main opportunities: 1) Gain visibility by participating in showcases, congresses, and competitions and 2) Leverage a network of experts to develop our business optimally: the best way to solve issues is by asking our peers and mentors, and Tech4Eva can provide both!
CareNX is an Indian healthtech start-up which develops & commercializes AI based technologies for women and child health. CareNX's product suit is being used by 1000+ hospitals, 3000+ doctors, 4+ state governments and 6 other countries in SE Asia and Africa and has collectively screened more than 500,000 pregnancies. The impactful work of CareNX has been felicitated by Hon’ble PM Shri. Modi, HM The Queen of England, PM of Great Britain, Commonwealth Secretariat, WHO Director and many more.
Tech4Eva has been instrumental in CareNX’s journey by providing global visibility, investor connections, mentorship support, and a robust partner network. Being part of the 2024 Tech4Eva cohort has been a source of immense pride for us, helping us establish early traction in the market.
CC Diagnostics is an in vitro diagnostic device manufacturer, developing a novel qPCR test for cervical cancer screening. Our Methica test evaluates the levels of methylation of a panel of proprietary tumor-suppressor genes. With this test we can detect up to 97% of all cervical cancer cases, saving thousands of lives and healthcare cost. Our test is compatible with self-collected samples, enabling full cervical screening from home. The assay is best positioned for automation and high-throughput laboratory settings.
Securing seed funding, analytical validation of the diagnostic product, completion of the 1st clinical trial, successful stability study, implementation of a QMS system per ISO13485 as well as winning competitions and grants.
Sound boarding with peers and sharing experiences from industry leaders across various backgrounds—marketing, sales, investment, and M&A — forces you to critically assess your organization. This helps you grow and improve in meaningful ways.
Cosm Medical is personalizing gynecological devices for precision care. By leveraging AI, Digital Gynecology software, and 3D printing, Coms has developed Gynethotics™ Pessaries tailored for individual needs. With positive clinical study outcomes and clearance from FDA and Health Canada, these devices address the quality of life and access issues associated with pelvic floor disorders which affect millions of women. Beyond pessaries, Cosm is pioneering a new product category in gynecology to improve the continuum of pelvic care from obstetrics to elderly care ushering in an age of Digital Gynecology.
The Tech4Eva program is a great help for our company, opening doors to the European market, facilitating invaluable external feedback, and fostering essential connections. We are excited about the opportunities ahead!
DeepLook Medical is enhancing Medical Imaging with revolutionary technology. We are creating a future where data-driven imaging enables accurate, efficient, and personalized care across the entire treatment pathway. Flagship product, FDA-cleared DL Precise™ is utilized by Radiologists to automate lesion segmentation, measurement, and visualization with unprecedented precision - all with a single click, especially in dense tissue.
EndoCure provides robotic AI-powered high-resolution ultrasound imaging for superior endometriosis diagnosis and management. Endometriosis, an ailment associated with chronic debilitating pain and infertility impacting 10% of reproductive-age women (equivalent to 200 million globally), poses a significant challenge due to the lack of precise diagnostic tools, resulting in an up to 11-year diagnosis delay. Our solution represents a transformative leap forward not only in the initial diagnosis but also in routine follow-up and surgical planning. It stands alone as the premiere solution offering a comprehensive lesion map to facilitate personalized treatment.
Endocure was awarded a $1million grant from Israel Innovation Authority in 2024.
The Tech4Eva program is specific to Femtech, and therefore my mentor’s guidance is exactly to the point.
Galena Innovations is developing the Hannah Cervical Cup, the solution to spontaneous preterm birth. Our mission is to change the trajectory of obstetrics from stagnation to innovation by creating solutions that meet the needs of mothers everywhere, from Mississippi to Malawi, ending the health and social inequities that are pervasive in our world, beginning with birth.
Hannah Cervical Cup prototypes - cervical model study - in vitro study and a Cadaver study, demonstrating the product's robustness and reliability. Patent in 2022 with more in process.
The program of Tech4Eva is invaluable to me because it provides access to mentorship from industry experts and a community of like-minded innovators. This support is crucial for accelerating the development and success of Galena Innovations.
Harmonia is a highly specialized women's health platform that combines cutting edge functional medicine treatment with science-backed resolution for underdiagnosed, undertreated and otherwise dismissed female-specific diseases. Initially focused on hyperemesis gravidarum and severe nausea and vomiting during pregnancy, Harmonia's physician-lead research, prognostic, and treatment programs result in superior health outcomes and subsequently enhanced wellbeing and quality of life.
Opened 1st treatment center.
Being able to take advantage of the guidance from seasoned professionals is an immensely valuable resource, particularly in the early stages of company development as company strategy is being developed.
HeroSupport focuses on developing patient-specific devices, particularly immobilization devices using additive manufacturing techniques. We provide comprehensive solutions for radiation-oncology professionals, enabling them to deliver precise and personalized treatments while enhancing patient comfort and reducing treatment times. Our first product, Venus Shell, is designed for breast cancer.
Closed 1st seed round - built a team - established a lab. Top Swiss Startup in 2024. 1st patent approval.
Hormona is reinventing hormone health for women through AI and at home testing. We are the first end-to-end solution for hormone health offering a revolutionary way of testing, monitoring and treatment of hormone issues while completely removing the need for a lab. With Hormona women receive lab grade results in 15 minutes from home alongside actionable tips and guides on how to stabilise and optimise their hormone health. By combining a range of tools from telehealth appointments to symptom reduction plans and medication, Hormona is the first solution addressing hormone related issues while pioneering the area of "Hormone Health”.
As a start-up you have many limitations, especially in how quickly you can grow your team so to be able to get advice, mentorship, guidance, and peer support through an initiative like Tech4Eva helps start-ups like us to get further with less. It is also great from a synergy point of view as there could be some fantastic opportunities to team up with other companies in this space to collectively drive women's health forward.
Mamotest is revolutionizing breast cancer care with a holistic, end-to-end solution designed to reduce mortality rates and address the inefficiencies of fragmented healthcare systems.
Mamotest developed Bolder, a digital platform designed to connect awareness, screening, diagnosis, and treatment solutions in one place, and track and trace patient journeys to ensure women receive timely, high-quality care. The platform not only ensures efficient follow-up but also structures data to drive business intelligence and evidence-based decision-making. By connecting demand and supply, and providing teleradiology and patient support services, Mamotest creates a seamless experience for women, reducing delays and improving outcomes.
Tech4Eva’s program has been a great opportunity to connect, share, and get support from fellows and entrepreneurs facing similar challenges in the FemTech Health field. Enriching advice from mentors and experts has also helped Mamotest shape the strategy to expand within the European market. Thank you very much to Tech4Eva's team, which has been extremely supportive throughout the program!
Namida is a biotechnology startup specializing in developing and commercializing early cancer detection proteomics tests. Namida’s first product is Auria, the first at-home biological breast cancer screening test powered by tears. Auria will improve the health outcomes for women through convenient early breast cancer detection and presents the opportunity to disrupt the breast cancer screening market that is clinically confusing and has lacked innovation.
Being part of the 2024 Tech4Eva allows us to be apart of the global Femtech innovation community and connect with fellow innovators, entrepreneurs, and investors. Thanks to the Tech4Eva accelerator program, we will raise awareness for advances in breast cancer screening with convenient and accessible breast cancer screening lab tests
Sin Reglas is a one-stop shop for women in menopause that complements DEI efforts and integrates diagnostics, health education, support community for the adoption of healthy habits, health care and marketplace. We have the passion and the commitment to transform the experience of menopause for ALL women so that we can lead healthy and purposeful lives.
1st study on menopause in Mexico with over 3000ppl. Initiating a reform of the Federal Labor Law in Mexico City to support women during menopause.
Tech4Eva’s program has been an incredible opportunity to learn and to give visibility to SinReglas, our mission and our work. We are deeply grateful for Simone Theiss and the whole Tech4Eva team.
Vital Start Health is a University of Pennsylvania startup with a vision of revolutionizing the $500b women’s mental health opportunity starting with a reproductive and maternity mental health platform using Virtual Reality for clinically guided care across pre-conception, birthing and postpartum. Our platform empowers moms and mental health practitioners to prevent and treat Perinatal Mood and Anxiety Disorders more effectively, equitably, and faster using Virtual and Augmented Reality Framework that measures and personalizes care at every stage of the wellness journey on-site at a clinic, health system or workplace and continuing at home virtually.
OvulaRing is the most sophisticated menstrual cycle tracker. It collects 288 temperature data points/day and uses AI for real-time fertile day detection. Useable for non-hormonal contraception, as well as conception and for menstrual cycle-based training. Success rates are higher than with IVF.
Being selected for the Tech4Eva Accelerator as the only German Femtech company this year has been incredibly valuable. The connections we've made and the inspiring support are helping us drive growth and further develop our vision.
CareNX is an Indian healthtech start-up which develops & commercializes AI based technologies for women and child health. CareNX's product suit is being used by 1000+ hospitals, 3000+ doctors, 4+ state governments and 6 other countries in SE Asia and Africa and has collectively screened more than 500,000 pregnancies. The impactful work of CareNX has been felicitated by Hon’ble PM Shri. Modi, HM The Queen of England, PM of Great Britain, Commonwealth Secretariat, WHO Director and many more.
Tech4Eva has been instrumental in CareNX’s journey by providing global visibility, investor connections, mentorship support, and a robust partner network. Being part of the 2024 Tech4Eva cohort has been a source of immense pride for us, helping us establish early traction in the market.
Galena Innovations is developing the Hannah Cervical Cup, the solution to spontaneous preterm birth. Our mission is to change the trajectory of obstetrics from stagnation to innovation by creating solutions that meet the needs of mothers everywhere, from Mississippi to Malawi, ending the health and social inequities that are pervasive in our world, beginning with birth.
Hannah Cervical Cup prototypes - cervical model study - in vitro study and a Cadaver study, demonstrating the product's robustness and reliability. Patent in 2022 with more in process.
The program of Tech4Eva is invaluable to me because it provides access to mentorship from industry experts and a community of like-minded innovators. This support is crucial for accelerating the development and success of Galena Innovations.
Harmonia is a highly specialized women's health platform that combines cutting edge functional medicine treatment with science-backed resolution for underdiagnosed, undertreated and otherwise dismissed female-specific diseases. Initially focused on hyperemesis gravidarum and severe nausea and vomiting during pregnancy, Harmonia's physician-lead research, prognostic, and treatment programs result in superior health outcomes and subsequently enhanced wellbeing and quality of life.
Opened 1st treatment center.
Being able to take advantage of the guidance from seasoned professionals is an immensely valuable resource, particularly in the early stages of company development as company strategy is being developed.
Cosm Medical is personalizing gynecological devices for precision care. By leveraging AI, Digital Gynecology software, and 3D printing, Coms has developed Gynethotics™ Pessaries tailored for individual needs. With positive clinical study outcomes and clearance from FDA and Health Canada, these devices address the quality of life and access issues associated with pelvic floor disorders which affect millions of women. Beyond pessaries, Cosm is pioneering a new product category in gynecology to improve the continuum of pelvic care from obstetrics to elderly care ushering in an age of Digital Gynecology.
The Tech4Eva program is a great help for our company, opening doors to the European market, facilitating invaluable external feedback, and fostering essential connections. We are excited about the opportunities ahead!
Hormona is reinventing hormone health for women through AI and at home testing. We are the first end-to-end solution for hormone health offering a revolutionary way of testing, monitoring and treatment of hormone issues while completely removing the need for a lab. With Hormona women receive lab grade results in 15 minutes from home alongside actionable tips and guides on how to stabilise and optimise their hormone health. By combining a range of tools from telehealth appointments to symptom reduction plans and medication, Hormona is the first solution addressing hormone related issues while pioneering the area of "Hormone Health”.
As a start-up you have many limitations, especially in how quickly you can grow your team so to be able to get advice, mentorship, guidance, and peer support through an initiative like Tech4Eva helps start-ups like us to get further with less. It is also great from a synergy point of view as there could be some fantastic opportunities to team up with other companies in this space to collectively drive women's health forward.
Vital Start Health is a University of Pennsylvania startup with a vision of revolutionizing the $500b women’s mental health opportunity starting with a reproductive and maternity mental health platform using Virtual Reality for clinically guided care across pre-conception, birthing and postpartum. Our platform empowers moms and mental health practitioners to prevent and treat Perinatal Mood and Anxiety Disorders more effectively, equitably, and faster using Virtual and Augmented Reality Framework that measures and personalizes care at every stage of the wellness journey on-site at a clinic, health system or workplace and continuing at home virtually.
Babyndex, created by a gynecologist and his economist son, features an FDA-approved microscope paired with a mobile app to analyze saliva crystals for fertility tracking. The app identifies the most fertile days, helping women to effectively track their fertility. Available for iOS and Android, Babyndex is proven to aid users trying to conceive, offering a user-friendly design and reliable results.
OvulaRing is the most sophisticated menstrual cycle tracker. It collects 288 temperature data points/day and uses AI for real-time fertile day detection. Useable for non-hormonal contraception, as well as conception and for menstrual cycle-based training. Success rates are higher than with IVF.
Being selected for the Tech4Eva Accelerator as the only German Femtech company this year has been incredibly valuable. The connections we've made and the inspiring support are helping us drive growth and further develop our vision.
Sin Reglas is a one-stop shop for women in menopause that complements DEI efforts and integrates diagnostics, health education, support community for the adoption of healthy habits, health care and marketplace. We have the passion and the commitment to transform the experience of menopause for ALL women so that we can lead healthy and purposeful lives.
1st study on menopause in Mexico with over 3000ppl. Initiating a reform of the Federal Labor Law in Mexico City to support women during menopause.
Tech4Eva’s program has been an incredible opportunity to learn and to give visibility to SinReglas, our mission and our work. We are deeply grateful for Simone Theiss and the whole Tech4Eva team.
Calico Biosystems is addressing the critical unmet need of the poor efficacy of cancer therapeutics for female patients with cancers. Cancer is a leading cause of death which kills one in six women. A main cause is the artificial models currently used for testing anti-cancer drug efficacy; they fail to recapitulate patient tumor complexity. Consequently, most anti-cancer drugs fail to reach approval due to a lack of efficacy and are extremely costly to develop. Further, approved anti-cancer drugs benefit only 10% of cancer patients. Calico Biosystems is the first platform testing drugs directly on female patient tumors thus predicting reliably at the pre-clinical stage the efficacy of drugs in patients.
Calico Biosystems drug testing platform is a game changer in precision oncology with aims at delivering female cancer patients with more potent and affordable drugs.
Being part of Tech4Eva brought us 2 main opportunities: 1) Gain visibility by participating in showcases, congresses, and competitions and 2) Leverage a network of experts to develop our business optimally: the best way to solve issues is by asking our peers and mentors, and Tech4Eva can provide both!
Ablatus is the creator of Luna, a minimally invasive, uterus-preserving, and inclusive treatment for fibroids. These tumours, which grows in the womb affect up to 80% of women by the age of 50 - with up to half of them affected with debilitating symptoms like period for up to 21 days, impacting quality of life, fertility, and productivity.
Luna is powered by our patented enhanced ablation platform that can be used to destroy cancerous and non-cancerous soft tissues.
Treatment is delivered via a steerable probe through the cervix to tackle hard-to-reach fibroids for up to 80% of women currently not eligible for state-of-the-art technologies without removing the uterus but wishing to avoid invasive surgery.
Stealth mode
CC Diagnostics is an in vitro diagnostic device manufacturer, developing a novel qPCR test for cervical cancer screening. Our Methica test evaluates the levels of methylation of a panel of proprietary tumor-suppressor genes. With this test we can detect up to 97% of all cervical cancer cases, saving thousands of lives and healthcare cost. Our test is compatible with self-collected samples, enabling full cervical screening from home. The assay is best positioned for automation and high-throughput laboratory settings.
Securing seed funding, analytical validation of the diagnostic product, completion of the 1st clinical trial, successful stability study, implementation of a QMS system per ISO13485 as well as winning competitions and grants.
Sound boarding with peers and sharing experiences from industry leaders across various backgrounds—marketing, sales, investment, and M&A — forces you to critically assess your organization. This helps you grow and improve in meaningful ways.
DeepLook Medical is enhancing Medical Imaging with revolutionary technology. We are creating a future where data-driven imaging enables accurate, efficient, and personalized care across the entire treatment pathway. Flagship product, FDA-cleared DL Precise™ is utilized by Radiologists to automate lesion segmentation, measurement, and visualization with unprecedented precision - all with a single click, especially in dense tissue.
EndoCure provides robotic AI-powered high-resolution ultrasound imaging for superior endometriosis diagnosis and management. Endometriosis, an ailment associated with chronic debilitating pain and infertility impacting 10% of reproductive-age women (equivalent to 200 million globally), poses a significant challenge due to the lack of precise diagnostic tools, resulting in an up to 11-year diagnosis delay. Our solution represents a transformative leap forward not only in the initial diagnosis but also in routine follow-up and surgical planning. It stands alone as the premiere solution offering a comprehensive lesion map to facilitate personalized treatment.
Endocure was awarded a $1million grant from Israel Innovation Authority in 2024.
The Tech4Eva program is specific to Femtech, and therefore my mentor’s guidance is exactly to the point.
HeroSupport focuses on developing patient-specific devices, particularly immobilization devices using additive manufacturing techniques. We provide comprehensive solutions for radiation-oncology professionals, enabling them to deliver precise and personalized treatments while enhancing patient comfort and reducing treatment times. Our first product, Venus Shell, is designed for breast cancer.
Closed 1st seed round - built a team - established a lab. Top Swiss Startup in 2024. 1st patent approval.
Mamotest is revolutionizing breast cancer care with a holistic, end-to-end solution designed to reduce mortality rates and address the inefficiencies of fragmented healthcare systems.
Mamotest developed Bolder, a digital platform designed to connect awareness, screening, diagnosis, and treatment solutions in one place, and track and trace patient journeys to ensure women receive timely, high-quality care. The platform not only ensures efficient follow-up but also structures data to drive business intelligence and evidence-based decision-making. By connecting demand and supply, and providing teleradiology and patient support services, Mamotest creates a seamless experience for women, reducing delays and improving outcomes.
Tech4Eva’s program has been a great opportunity to connect, share, and get support from fellows and entrepreneurs facing similar challenges in the FemTech Health field. Enriching advice from mentors and experts has also helped Mamotest shape the strategy to expand within the European market. Thank you very much to Tech4Eva's team, which has been extremely supportive throughout the program!
Namida is a biotechnology startup specializing in developing and commercializing early cancer detection proteomics tests. Namida’s first product is Auria, the first at-home biological breast cancer screening test powered by tears. Auria will improve the health outcomes for women through convenient early breast cancer detection and presents the opportunity to disrupt the breast cancer screening market that is clinically confusing and has lacked innovation.
Being part of the 2024 Tech4Eva allows us to be apart of the global Femtech innovation community and connect with fellow innovators, entrepreneurs, and investors. Thanks to the Tech4Eva accelerator program, we will raise awareness for advances in breast cancer screening with convenient and accessible breast cancer screening lab tests